Inhibitory activities of microalgal extracts against Epstein-Barr virus DNA release from lymphoblastoid cells

Journal of Zhejiang University: Science B

Volumn 12, Issue 5, 2011, Pages 335-345

  Kok, Yih Yih ^a   Chu, Wan Loy ^a   Phang, Siew Moi ^b   Mohamed, Shar Mariam ^a   Naidu, Rakesh ^c,d   Lai, Pey Jiun ^c   Ling, Shui Nyuk ^a   Mak, Joon Wah ^a   Lim, Patricia Kim Chooi ^e   Balraj, Pauline ^e   Khoo, Alan Soo Beng ^e  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c UNIVERSITY OF MALAYA   (Malaysia)

^d MONASH UNIVERSITY MALAYSIA   (Malaysia)

^e INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

Author keywords

Ankistrodesmus convolutus; Epstein Barr virus (EBV); Lymphoblastoid cells; Microalgae; Spirulina platensis; Synechococcus elongatus

Indexed keywords

ACICLOVIR; ALGAL EXTRACT; ANKISTRODESMUS CONVOLUTUS EXTRACT; FOSCARNET; SPIRULINA EXTRACT; SYNECHOCOCCUS ELONGATUS EXTRACT; UNCLASSIFIED DRUG; VIRUS DNA;

ANKISTRODESMUS CONVOLUTUS; ANTIVIRAL ACTIVITY; ARTICLE; BACTERIUM; BIOMASS; BURKITT LYMPHOMA; CELL EXPANSION; CELL FREE SYSTEM; CELL LINE; COLUMN CHROMATOGRAPHY; CYTOTOXICITY; DNA EXTRACTION; EPSTEIN BARR VIRUS; FRACTIONATION; GENE AMPLIFICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LYMPHOBLASTOID CELL; MICROALGA; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPIRULINA PLATENSIS; SYNECHOCOCCUS ELONGATUS; VIRUS LOAD;

ACYCLOVIR; ANTIVIRAL AGENTS; BASE SEQUENCE; BURKITT LYMPHOMA; CELL LINE, TUMOR; CHLOROPHYTA; DNA, VIRAL; FOSCARNET; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOID PROGENITOR CELLS; MICROALGAE; POLYMERASE CHAIN REACTION; SPIRULINA; SYNECHOCOCCUS; VIRAL LOAD;

ANKISTRODESMUS CONVOLUTUS; HUMAN HERPESVIRUS 4; SPIRULINA PLATENSIS; SYNECHOCOCCUS ELONGATUS;

EID: 79956225048     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1000336     Document Type: Article

References (30)

1. A.L. Adamson D. Darr E. Holley-Guthrie R.A. Johnson A. Mauser J. Swenson S. Kenney 2000 Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases J. Virol. 74 3 1224 1233 10627532 10.1128/JVI.74.3.1224-1233.2000 1:CAS:528:DC%2BD3cXmtFyiug%3D%3D (Pubitemid 30044071)
2. T. Akihisa Y. Taguchi K. Yasukawa H. Tokuda H. Akazawa T. Suzuki Y. Kimura 2006 Acerogenin M, a cyclic diarylheptanoid, and other phenolic compounds from Acer nikoense and their anti-inflammatory and anti-tumor-promoting effects Chem. Pharm. Bull. 54 5 735 739 16651781 10.1248/cpb.54.735 1:CAS:528:DC%2BD28Xmt1ehsbo%3D
3. M. Ballout R. Germi S. Fafi-Kremer J. Guimet G. Bargues J. Seigneurin P. Morand 2007 Real-time quantitative PCR for assessment of antiviral drug effects against Epstein-Barr virus replication and EBV late mRNA expression J. Virol. Methods 143 1 38 44 17368820 10.1016/j.jviromet.2007.02.005 1:CAS:528: DC%2BD2sXlvVOms74%3D (Pubitemid 46802823)
4. C.B. Buck C.D. Thompson J.N. Roberts M. Müller D.R. Lowy J.T. Schiller 2006 Carrageenan is a potent inhibitor of papillomavirus infection PLoS Pathogens 2 7 e69 16839203 10.1371/journal.ppat.0020069 (Pubitemid 44147420)
5. Y. Chang C.H. Tung Y.T. Huang J. Lu J.Y. Chen C.H. Tsai 1999 Requirement of cell to cell contact in EBV infection of NPC and keratinocytes J. Virol. 73 10 8857 8866 10482644 1:CAS:528:DyaK1MXlvFyqsLg%3D
6. A. Chêne D. Donati A.O. Guerreriro-Cacais V. Levitsky Q. Chen K.I. Falk J. Orem F. Kironde M. Wahlgren M.T. Bejarano 2007 A molecular link between malaria and Epstein-Barr virus reactivation PLoS Pathogens 3 6 e80 17559303 10.1371/journal.ppat.0030080 (Pubitemid 47015882)
7. W.L. Chu S.M. Phang S.H. Goh 1995 Influence of carbon source on the growth, biochemical composition and pigmentation of Ankistrodesmus convolutus J. Appl. Phycol. 7 1 59 64 10.1007/BF00003551 1:CAS:528:DyaK2MXkvF2ju7g%3D
8. M. Daibata K. Bandobashi M. Kuroda S. Imai I. Miyoshi H. Taguchi 2005 Induction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivo J. Virol. 79 9 5875 5879 15827204 10.1128/JVI.79.9.5875-5879.2005 1:CAS:528:DC%2BD2MXjslSjs7c%3D (Pubitemid 40548258)
9. C.Y. Fang C.H. Lee C.C. Wu Y.T. Chang S.L. Yu S.P. Chou P.T. Huang C.L. Chen J.W. Hou Y. Chang, et al. 2009 Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells Int. J. Cancer 124 9 2016 2025 19132751 10.1002/ijc.24179 1:CAS:528:DC%2BD1MXktVWntbo%3D
10. P. Feng E.C. Ren D. Liu S.H. Chan H. Hu 2000 Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: potential use in diagnosis J. Gen. Virol. 81 Pt10 2417 2423 10993929 1:CAS:528:DC%2BD3cXnt12hsr4%3D
11. E. Gershburg J.S. Pagano 2005 Epstein-Barr virus infections: prospects for treatment J. Antimicrob. Chemother. 56 2 277 281 16006448 10.1093/jac/dki240 1:CAS:528:DC%2BD2MXmvVOjsL0%3D (Pubitemid 41158513)
12. J.A. Hemmingson R. Falshaw R.H. Furneaux K. Thompson 2006 Structure and antiviral activity of the galactofucan sulfates extracted from Undaria pinnatifida (Phaeophyta) J. Appl. Phycol. 18 2 185 193 10.1007/s10811-006-9096-9 1:CAS:528:DC%2BD28Xot12jsL4%3D (Pubitemid 44259567)
13. M. Huleihel V. Ishanu J. Tal S. Arad 2001 Antiviral effect of red microalgal polysaccharides on Herpes simplex and Varicella zoster viruses J. Appl. Phycol. 13 2 127 134 10.1023/A:1011178225912 1:CAS:528: DC%2BD3MXkvVOmtLo%3D (Pubitemid 32489161)
14. G. Klein 1994 Epstein-Barr virus strategy in normal and neoplastic B cells Cell 77 6 791 793 8004668 10.1016/0092-8674(94)90125-2 1:CAS:528:DyaK2cXksl2ksLs%3D (Pubitemid 24187676)
15. A. Krenauer A. Moll W. Ponisch N. Schmitz G. Niedobitek D. Niederwieser T. Aigner 2010 EBV-associated post-transplantation B-cell lymphoproliferative disorder following allogenic stem cell transplantation for acute lymphoblastic leukaemia: tumor regression after reduction of immunosuppression-a case report Diagn. Pathol. 5 1 21 20356360 10.1186/1746-1596-5-21
16. J. Kurth T. Spieker J. Wustrow G.J. Strickler L.M. Hansmann K. Rajewsky R. Küppers 2000 EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency Immunity 13 4 485 495 11070167 10.1016/S1074-7613(00)00048-0 1:CAS:528:DC%2BD3cXnsl2ntrg%3D
17. P.J. Lai W.L. Chu R. Naidu A.S.B. Khoo Y.Y. Kok M.M. Shar S.N. Ling J.W. Mak K.C. Lim P. Balraj, et al. 2008 Antiproliferative activity of microalgal extracts on nasopharyngeal carcinoma (NPC) cells Malaysian J. Sci. 27 2 19 31 1:CAS:528:DC%2BD1MXitF2gt70%3D
18. J.C. Lin 2003 Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro Antiviral Res. 59 1 41 47 12834859 10.1016/S0166-3542(03)00030-5 1:CAS:528:DC%2BD3sXkvF2htr0%3D (Pubitemid 36773889)
19. T.P. Lin S.Y. Chen P.D. Duh L.K. Chang Y.N. Liu 2008 Inhibition of the Epstein-Barr virus lytic cycle by andrographolide Biol. Pharm. Bull. 31 11 2018 2023 18981566 10.1248/bpb.31.2018 1:CAS:528:DC%2BD1MXjtFCksg%3D%3D
20. D.Y.M. Lo L.Y.S. Chan K.W. Lo S.F. Leung J. Zhang A.T.C. Chan J.C.K. Lee N.M. Hjelm P.J. Johnson D.P. Huang 1999 Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma Cancer Res. 59 1188 1191 10096545 1:CAS:528:DyaK1MXhvFeht7k%3D (Pubitemid 29136244)
21. T. Mosmann 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1-2 55 63 6606682 10.1016/0022-1759(83)90303-4 1:STN:280: DyaL2c%2FovFSmtw%3D%3D (Pubitemid 14203433)
22. H. Ohigashi Y. Sakai K. Yamaguchi I. Umezaki K. Koshimizu 1992 Possible anti-tumor promoting properties of marine algae and in vivo activity of Wakame seaweed extract Biosci. Biotechnol. Biochem. 56 6 994 995 1369377 10.1271/bbb.56.994 1:STN:280:DyaK38zgsFCltA%3D%3D
23. Phang, S.M.; Chu, W.L.; 1999. University of Malaya Algae Culture Collection (UMACC): Catalogue of Strains. Institute of Postgraduate Studies and Research, University of Malaya, Kuala Lumpur, Malaysia, p.77.
24. S. Rechter T. König S. Auerochs S. Thulke H. Walter H. Dörnenburg C. Walter M. Marschall 2006 Antiviral activity of Arthrospira-derived spirulan-like substances Antiviral Res. 72 3 197 206 16884788 10.1016/j.antiviral.2006.06.004 1:CAS:528:DC%2BD28Xht1ShtLjE (Pubitemid 44708302)
25. S. Rezk L. Weiss 2007 Epstein-Barr virus-associated lymphoproliferative disorders Human Pathol. 38 9 1293 1304 10.1016/j.humpath.2007.05.020 1:CAS:528:DC%2BD2sXpt1entL8%3D (Pubitemid 47247493)
26. Rickinson, A.B.; Kieff, E.; 1996. Epstein-Barr Virus. In: Fields, B.N.; Knipe, B.N.; Howley, P.M. (Eds.), Fields Virology. Lippincott-Williams and Wilkins, Philadelphia, p.2397-2476.
27. F.D. Rocha A.R. Soares P.J. Houghton R.C. Pereira M.A.C. Kaplan V.L. Teixeira 2007 Potential cytotoxic activity of some Brazilian seaweeds on human melanoma cells Phytother. Res. 21 2 170 175 17133653 10.1002/ptr.2038
28. F. Schwarzmann M. Jager M. Horner N. Prang H. Wolf 1998 Epstein-Barr viral gene expression in B-lymphocytes Leuk. Lymphoma 30 1-2 123 129 9669682 1:CAS:528:DC%2BD3cXisFOht7c%3D (Pubitemid 28327261)
29. K. Takada N. Shimizu A. Tanabe-Tochikura Y. Kuroiwa 1995 Pathogenic role of Epstein-Barr virus in human cancer Intervirology 38 3-4 214 220 8682619 1:CAS:528:DyaK28XpslOqtQ%3D%3D (Pubitemid 26009395)
30. D.M. Walling C.M. Flaitz C.M. Nicholas 2003 Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir J. Infect. Dis. 188 6 883 890 12964120 10.1086/378072 1:CAS:528:DC%2BD3sXotl2gt7Y%3D (Pubitemid 37176035)